Sector
PharmaceuticalsOpen
₹11.93Prev. Close
₹11.5Turnover(Lac.)
₹0.5Day's High
₹11.93Day's Low
₹11.552 Week's High
₹24.8252 Week's Low
₹9.64Book Value
₹2.43Face Value
₹10Mkt Cap (₹ Cr.)
9.55P/E
0EPS
0Divi. Yield
07 Sep 2024
12:00 AM
AGM
Announcement Date: 07 Sep, 2024
10 Jul 2025
12:00 AM
Board Meeting
Agenda : Audited Result
| Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
Equity Capital | 8.13 | 8.13 | 8.13 | 8.13 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | -5.31 | 2.73 | 2.83 | 3.22 |
Net Worth | 2.82 | 10.86 | 10.96 | 11.35 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Revenue | 8.16 | 197.39 | 79.71 | 61.88 |
yoy growth (%) | -95.86 | 147.63 | 28.8 | -1.67 |
Raw materials | -3.95 | -154.62 | -57.59 | -40.72 |
As % of sales | 48.36 | 78.33 | 72.24 | 65.8 |
Employee costs | -1.05 | -5.35 | -3.32 | -3.34 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Profit before tax | 0.13 | 0.71 | 0.68 | 1.13 |
Depreciation | -0.28 | -1.95 | -1.68 | -1.7 |
Tax paid | 0.8 | -1.28 | 0 | -0.62 |
Working capital | -19.52 | -3.33 | 2.94 | 3.15 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | -95.86 | 147.63 | 28.8 | -1.67 |
Op profit growth | -78.18 | 5.72 | -0.76 | -7.62 |
EBIT growth | -74.28 | -5.76 | 2.65 | -15.72 |
Net profit growth | -267.66 | -183.02 | 34.97 | -39.65 |
| Particulars (Rupees in Crores.) | Mar-2012 |
|---|---|
Gross Sales | 78.91 |
Excise Duty | 0 |
Net Sales | 78.91 |
Other Operating Income | 6.88 |
Other Income | 0.25 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,672 | 93.86 | 4,01,288.77 | 2,000.46 | 0.96 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,835 | 82.12 | 1,81,397.34 | 667 | 0.44 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,485 | 24.92 | 1,19,948.65 | 1,485.4 | 1.08 | 4,254.47 | 397.41 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,314.2 | 59.26 | 1,12,127.01 | 474 | 0.18 | 2,385 | 224.34 |
Mankind Pharma Ltd MANKIND | 2,578.3 | 56.47 | 1,06,401.47 | 382.46 | 0 | 2,126.59 | 354.71 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Managing Director
S Murali Krishna Murthy
Non Executive Director
S Balaji Venkateswarlu
Whole Time Director & CFO
S Srinivas Kumar
Independent Director
B Gopal Reddy
Independent Director
Murali Krishna Rayaprolu
Independent Director
Pottur Sujatha
Non Executive Director
Pramod Dnyandeo Wag He
Non Executive Director
Shashikant Shankarrao Igave
Non Executive Director
Rutvikbhai Mukeshbhai Beladiya
Independent Director
Smitaben Suthar
Independent Director
Pratik Bharatbhai Panchal
Whole Time Director
Ramesh Joshi
D No 1-8-B4 Ground Floor F3,
HIG Block-4 Street No 3,
Telangana - 500044
Tel: -
Website: http://www.ortinlabsindia.com
Email: info@ortinlabsindia.com
Karvy Selenium Tow-B,
31&32 Financial Dist, Nanakramguda,
Hyderabad-500032
Tel: 91-40-67162222
Website: www.kfintech.com
Email: einward.ris@kfintech.com
Summary
Ortin Laboratories Limited was incorporated in October, 1986 with a nominal capital of Rs 1 lakh to offer quality Drugs and Medicines to the suffering mankind. The Company is a leading and predominant...
Read More
Reports by Ortin Laboratories Ltd
What is the Ortin Global Ltd share price today?
What is the Market Cap of Ortin Global Ltd?
What is the PE and PB ratio of Ortin Global Ltd?
What is the 52 Week High and Low of Ortin Global Ltd?
What is the CAGR of Ortin Global Ltd?
What is the shareholding pattern of Ortin Global Ltd?
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.